Insights from the 2022 R&D Innovation Survey
In this playbook, we share insights from 33 biopharma executives who reported their experience using these bellwether approaches for the 2022 R&D Innovation Survey conducted by Health Advances and Parexel Biotech. This innovation snapshot shows biotechs adopting new approaches and encountering a variety of roadblocks, but pushing forward to expand their use and deliver faster, more efficient development.
Considered as a whole, findings from the December 2022 R&D Innovation Survey lead us to three top-line insights:
- Regulatory and commercial strategies must be considered earlier.
- Adaptive designs, ECAs and DCTs are growing in importance.
- Biopharma must pursue new ways to increase diversity in clinical trials.
Related Insights
Podcast
Enabling Successful Sites, Episode 2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training
Jun 28, 2024
Podcast
Enabling Successful Sites, Episode 3: Taking the complexity out of oncology clinical trials
Jun 28, 2024
Blog
Decentralized Trials: Considerations for Building a New Patient-Centric Model
May 13, 2021
Article
How a joined-up development strategy pays off for early-stage biotechs
May 19, 2021
Blog
Master Protocol Trials: What Are the Elements of Success?
Dec 1, 2021
Article
4 Insights on decentralized trials for biotechs
Jul 1, 2021
Report
New Medicines, Novel Insights: Advancing rare disease drug development
May 22, 2023
Blog
Scientific Advances: Catalyst for Biotech Investment and Innovation in Clinical Development
Mar 12, 2024
Blog
Adapting the validation process for PROs for rare diseases and other diseases with large unmet need and/or rapid progression
Apr 23, 2024
Blog
Incorporating the patient voice in clinical research: Validation of COAs for a rare disease NDA
Nov 17, 2025
Article
8 things you need to know about eCTDs in China
Jul 1, 2022
Article
Getting to ‘No’ fast is more important when you are small
Mar 4, 2022
Related Insights
Podcast
Enabling Successful Sites, Episode 2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training
Jun 28, 2024
Podcast
Enabling Successful Sites, Episode 3: Taking the complexity out of oncology clinical trials
Jun 28, 2024
Blog
Decentralized Trials: Considerations for Building a New Patient-Centric Model
May 13, 2021
Article
How a joined-up development strategy pays off for early-stage biotechs
May 19, 2021
Blog
Master Protocol Trials: What Are the Elements of Success?
Dec 1, 2021
Article
4 Insights on decentralized trials for biotechs
Jul 1, 2021
Report
New Medicines, Novel Insights: Advancing rare disease drug development
May 22, 2023
Blog
Scientific Advances: Catalyst for Biotech Investment and Innovation in Clinical Development
Mar 12, 2024
Blog
Adapting the validation process for PROs for rare diseases and other diseases with large unmet need and/or rapid progression
Apr 23, 2024
Blog
Incorporating the patient voice in clinical research: Validation of COAs for a rare disease NDA
Nov 17, 2025
Article
8 things you need to know about eCTDs in China
Jul 1, 2022
Article
Getting to ‘No’ fast is more important when you are small
Mar 4, 2022